To further investigate ENO1-associated non-glycolytic metabolic pathways in tumor progression, we analyzed proteomic profiles of 110 GBM patients from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Here, ENO1 is linked to neoplasm.